ZYBT
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/S is extremely low, but Graham Number is unavailable due to lack of earnings.
- Very low P/S ratio (0.28)
- P/B near 1.0
- No earnings to support P/E
- Value is eroding due to negative growth
Growth metrics are severely distressed.
- Revenue growth is -34.40%
- Operating margins are deeply negative
Long-term and short-term price trends are aggressively bearish.
- 1Y return of -88.2%
- 5Y return of -81.1%
Balance sheet is the only stable component; Piotroski score is the primary positive driver.
- Piotroski F-Score 5/9
- Low leverage (D/E 0.23)
- Current Ratio 1.49
- Negative ROE and ROA
Non-dividend paying company.
- No dividend paid
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ZYBT and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ZYBT
Zhengye Biotechnology Holding Limited
Primary
|
-81.1% | -81.1% | -88.2% | -63.5% | +5.8% | -10.7% |
|
RLYB
Rallybio Corporation
Peer
|
-92.7% | -76.3% | +311.0% | +92.1% | -12.2% | -2.6% |
|
ARAY
Accuray Incorporated
Peer
|
-93.2% | -87.0% | -78.7% | -76.4% | -27.4% | -24.4% |
|
APLM
Apollomics, Inc.
Peer
|
-98.0% | -98.1% | +148.8% | +191.4% | -0.5% | -0.8% |
|
RNXT
RenovoRx, Inc.
Peer
|
-86.2% | -68.2% | -2.0% | -10.7% | -2.9% | +1.5% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q2 2025
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ZYBT
Zhengye Biotechnology...
|
BEARISH | $43.6M | - | -6.4% | -12.6% | $0.92 | |
|
RLYB
Rallybio Corporation
|
BEARISH | $43.48M | - | -15.0% | -% | $8.22 | Compare |
|
ARAY
Accuray Incorporated
|
BEARISH | $44.0M | - | -70.3% | -8.2% | $0.37 | Compare |
|
APLM
Apollomics, Inc.
|
BEARISH | $42.65M | - | -380.1% | -% | $19.9 | Compare |
|
RNXT
RenovoRx, Inc.
|
BEARISH | $45.05M | - | -225.6% | -% | $1.0 | Compare |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning ZYBT from our newsroom.